Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (171-180 of 284) with videos related to

Pageof 29
Sort By:
Plos One|October 27, 2010
Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague modelXiaodong Xiao, Zhongyu Zhu, Jennifer L Dankmeyer, et al.
Oncotarget|April 25, 2015
Assessment of folate receptor-β expression in human neoplastic tissuesJiayin Shen, Karson S Putt, Daniel W Visscher, et al.
Virology|April 24, 2018
Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier categorySaikat Boliar, Shilpa Patil, Brihaspati N Shukla, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Potent and Broad HIV-1 Neutralization by a Bispecific CD4-CD4i Fusion Protein based on Single-Domain CD4-D1 and X5 CD4i antibodyXiaojie Chu, Cory Shetler, Zeyu Sun, et al.
Nucleic Acids Research|September 23, 2003
Evaluation of gene expression measurements from commercial microarray platformsPaul K Tan, Thomas J Downey, Edward L Spitznagel, et al.
Journal of Virology|September 19, 2008
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor bindingKimberly A Bishop, Andrew C Hickey, Dimple Khetawat, et al.
The Journal of Infectious Diseases|March 5, 2016
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV InfectionKatherine V Houser, Lisa Gretebeck, Tianlei Ying, et al.
Mabs|March 11, 2016
Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1Weizao Chen, Ariola Bardhi, Yang Feng, et al.
Antiviral Research|July 11, 2013
A treatment for and vaccine against the deadly Hendra and Nipah virusesChristopher C Broder, Kai Xu, Dimitar B Nikolov, et al.
Journal of Virology|November 8, 2013
Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domainsWeizao Chen, Yang Feng, Ponraj Prabakaran, et al.
Pageof 29

Showing results (171-180 of 284) with videos related to

Sort By:
Pageof 29
Plos One|October 27, 2010
Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague modelXiaodong Xiao, Zhongyu Zhu, Jennifer L Dankmeyer, et al.
Oncotarget|April 25, 2015
Assessment of folate receptor-β expression in human neoplastic tissuesJiayin Shen, Karson S Putt, Daniel W Visscher, et al.
Virology|April 24, 2018
Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier categorySaikat Boliar, Shilpa Patil, Brihaspati N Shukla, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Potent and Broad HIV-1 Neutralization by a Bispecific CD4-CD4i Fusion Protein based on Single-Domain CD4-D1 and X5 CD4i antibodyXiaojie Chu, Cory Shetler, Zeyu Sun, et al.
Nucleic Acids Research|September 23, 2003
Evaluation of gene expression measurements from commercial microarray platformsPaul K Tan, Thomas J Downey, Edward L Spitznagel, et al.
Journal of Virology|September 19, 2008
Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor bindingKimberly A Bishop, Andrew C Hickey, Dimple Khetawat, et al.
The Journal of Infectious Diseases|March 5, 2016
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV InfectionKatherine V Houser, Lisa Gretebeck, Tianlei Ying, et al.
Mabs|March 11, 2016
Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1Weizao Chen, Ariola Bardhi, Yang Feng, et al.
Antiviral Research|July 11, 2013
A treatment for and vaccine against the deadly Hendra and Nipah virusesChristopher C Broder, Kai Xu, Dimitar B Nikolov, et al.
Journal of Virology|November 8, 2013
Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domainsWeizao Chen, Yang Feng, Ponraj Prabakaran, et al.
Pageof 29